150 related articles for article (PubMed ID: 36788095)
21. [Endometrial and other rare uterine sarcomas : Diagnostic aspects in the context of the 2020 WHO classification].
Mayr D; Horn LC; Hiller GGR; Höhn AK; Schmoeckel E
Pathologe; 2022 May; 43(3):183-195. PubMed ID: 35362728
[TBL] [Abstract][Full Text] [Related]
22. Utility of
Verma A; Menon S; Rekhi B; Pai T; Maheshwari A; Ghosh J; Gupta S; Deodhar K
Indian J Cancer; 2019; 56(4):335-340. PubMed ID: 31607703
[TBL] [Abstract][Full Text] [Related]
23. Identification of a novel, recurrent MBTD1-CXorf67 fusion in low-grade endometrial stromal sarcoma.
Dewaele B; Przybyl J; Quattrone A; Finalet Ferreiro J; Vanspauwen V; Geerdens E; Gianfelici V; Kalender Z; Wozniak A; Moerman P; Sciot R; Croce S; Amant F; Vandenberghe P; Cools J; Debiec-Rychter M
Int J Cancer; 2014 Mar; 134(5):1112-22. PubMed ID: 23959973
[TBL] [Abstract][Full Text] [Related]
24. Loss of p16
Aesif SW; Aubry MC; Yi ES; Kloft-Nelson SM; Jenkins SM; Spears GM; Greipp PT; Sukov WR; Roden AC
J Thorac Oncol; 2017 May; 12(5):860-871. PubMed ID: 28179162
[TBL] [Abstract][Full Text] [Related]
25. High-grade endometrial stromal sarcomas: a clinicopathologic study of a group of tumors with heterogenous morphologic and genetic features.
Sciallis AP; Bedroske PP; Schoolmeester JK; Sukov WR; Keeney GL; Hodge JC; Bell DA
Am J Surg Pathol; 2014 Sep; 38(9):1161-72. PubMed ID: 25133706
[TBL] [Abstract][Full Text] [Related]
26. Fluorescence in situ hybridization (FISH) provides estimates of minute and interstitial BAP1, CDKN2A, and NF2 gene deletions in peritoneal mesothelioma.
Brich S; Bozzi F; Perrone F; Tamborini E; Cabras AD; Deraco M; Stacchiotti S; Dagrada GP; Pilotti S
Mod Pathol; 2020 Feb; 33(2):217-227. PubMed ID: 31570769
[TBL] [Abstract][Full Text] [Related]
27. Endometrial stromal sarcoma--the new genetic paradigm.
Lee CH; Nucci MR
Histopathology; 2015 Jul; 67(1):1-19. PubMed ID: 25355621
[TBL] [Abstract][Full Text] [Related]
28. Molecular characterization of a population-based series of endometrial stromal sarcomas in Kuwait.
Ali RH; Al-Safi R; Al-Waheeb S; John B; Al-Ali W; Al-Jassar W; Al-Mulla F; Melnyk N; Huntsman DG; Lee CH
Hum Pathol; 2014 Dec; 45(12):2453-62. PubMed ID: 25288234
[TBL] [Abstract][Full Text] [Related]
29. Targeted RNA expression profiling identifies high-grade endometrial stromal sarcoma as a clinically relevant molecular subtype of uterine sarcoma.
Momeni-Boroujeni A; Mohammad N; Wolber R; Yip S; Köbel M; Dickson BC; Hensley ML; Leitao MM; Antonescu CR; Benayed R; Ladanyi M; Lee CH; Chiang S
Mod Pathol; 2021 May; 34(5):1008-1016. PubMed ID: 33077922
[TBL] [Abstract][Full Text] [Related]
30. High-grade transformation of low-grade endometrial stromal sarcomas lacking YWHAE and BCOR genetic abnormalities.
Zou Y; Turashvili G; Soslow RA; Park KJ; Croce S; McCluggage WG; Stewart CJR; Oda Y; Oliva E; Young RH; Da Cruz Paula A; Dessources K; Ashley CW; Hensley ML; Yip S; Weigelt B; Benayed R; Antonescu CR; Lee CH; Chiang S
Mod Pathol; 2020 Sep; 33(9):1861-1870. PubMed ID: 32317704
[TBL] [Abstract][Full Text] [Related]
31. YWHAE-rearranged high-grade endometrial stromal sarcoma: Two-center case series and response to chemotherapy.
Hemming ML; Wagner AJ; Nucci MR; Chiang S; Wang L; Hensley ML; George S
Gynecol Oncol; 2017 Jun; 145(3):531-535. PubMed ID: 28390819
[TBL] [Abstract][Full Text] [Related]
32. An Unusual Case of YWHAE-NUTM2A/B Endometrial Stromal Sarcoma With Confinement to the Endometrium and Lack of High-Grade Morphology.
Attygalle AD; Vroobel K; Wren D; Barton DP; Hazell SJ; Cin PD; Koelble K; McCluggage WG
Int J Gynecol Pathol; 2017 Mar; 36(2):165-171. PubMed ID: 27171540
[TBL] [Abstract][Full Text] [Related]
33. Novel EPC1 gene fusions in endometrial stromal sarcoma.
Dickson BC; Lum A; Swanson D; Bernardini MQ; Colgan TJ; Shaw PA; Yip S; Lee CH
Genes Chromosomes Cancer; 2018 Nov; 57(11):598-603. PubMed ID: 30144186
[TBL] [Abstract][Full Text] [Related]
34. Non-fusion mutations in endometrial stromal sarcomas: what is the potential impact on tumourigenesis through cell cycle dysregulation?
Patel SB; McCormack C; Hodge JC
J Clin Pathol; 2020 Dec; 73(12):830-835. PubMed ID: 32385140
[TBL] [Abstract][Full Text] [Related]
35. Differential mechanisms of CDKN2A (p16) alteration in oral tongue squamous cell carcinomas and correlation with patient outcome.
Lim AM; Do H; Young RJ; Wong SQ; Angel C; Collins M; Takano EA; Corry J; Wiesenfeld D; Kleid S; Sigston E; Lyons B; Fox SB; Rischin D; Dobrovic A; Solomon B
Int J Cancer; 2014 Aug; 135(4):887-95. PubMed ID: 24436120
[TBL] [Abstract][Full Text] [Related]
36. Small deletions but not methylation underlie CDKN2A/p16 loss of expression in conventional osteosarcoma.
Mohseny AB; Tieken C; van der Velden PA; Szuhai K; de Andrea C; Hogendoorn PC; Cleton-Jansen AM
Genes Chromosomes Cancer; 2010 Dec; 49(12):1095-103. PubMed ID: 20737480
[TBL] [Abstract][Full Text] [Related]
37. A Combination of MTAP and p16 Immunohistochemistry Can Substitute for CDKN2A Fluorescence In Situ Hybridization in Diagnosis and Prognosis of Pleural Mesotheliomas.
Brcic L; Le Stang N; Gallob F; Pissaloux D; Sequeiros R; Paindavoine S; Pairon JC; Karanian M; Dacic S; Girard N; Churg A; Tirode F; Galateau-Salle F
Arch Pathol Lab Med; 2023 Mar; 147(3):313-322. PubMed ID: 35738002
[TBL] [Abstract][Full Text] [Related]
38. Homozygous deletion of CDKN2A by fluorescence in situ hybridization is prognostic in grade 4, but not grade 2 or 3, IDH-mutant astrocytomas.
Marker DF; Pearce TM
Acta Neuropathol Commun; 2020 Oct; 8(1):169. PubMed ID: 33081848
[TBL] [Abstract][Full Text] [Related]
39. Novel High-grade Endometrial Stromal Sarcoma: A Morphologic Mimicker of Myxoid Leiomyosarcoma.
Hoang LN; Aneja A; Conlon N; Delair DF; Middha S; Benayed R; Hensley ML; Park KJ; Hollmann TJ; Hameed MR; Antonescu CR; Soslow RA; Chiang S
Am J Surg Pathol; 2017 Jan; 41(1):12-24. PubMed ID: 27631520
[TBL] [Abstract][Full Text] [Related]
40. Clinical characteristics and prognostic factors of endometrial stromal sarcoma and undifferentiated uterine sarcoma confirmed by central pathologic review: A multi-institutional retrospective study from the Japanese Clinical Oncology Group.
Kikuchi A; Yoshida H; Tsuda H; Nishio S; Suzuki S; Takehara K; Kino N; Sumi T; Kato K; Yokoyama M; Nakamura K; Takano M; Sato S; Kato H; Tamate M; Horie K; Kato T; Sakamoto A; Fukunaga M; Kaku T; Yoshida M; Yaegashi N; Satoh T
Gynecol Oncol; 2023 Sep; 176():82-89. PubMed ID: 37478616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
